Investigating the quality of hemovigilance process using the first two steps of Six Sigma model: a cross-sectional study.
Blood bank
Blood transfusion errors
Hemovigilance
Hospital
Patient safety
Quality improvement
Six sigma
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
15
04
2023
accepted:
04
10
2023
medline:
30
10
2023
pubmed:
28
10
2023
entrez:
27
10
2023
Statut:
epublish
Résumé
Hemovigilance is a set of monitoring methods that covers the blood transfusion chain, from collecting blood and blood products to monitoring the blood recipients. To this end, any error in this process can have serious and irreparable consequences for patients. The present study aimed to investigate the quality of hemovigilance process in Iran, using the first two steps of Six Sigma model. This was a quantitative cross-sectional study that was conducted over 6 months (from August 20, 2021, to February 20, 2022) at Afzalipour Hospital in Iran, using the first two steps of Six Sigma model. The study population comprised of all inpatients who needed blood or blood product transfusion in various departments of Afzalipour Hospital, among whom 477 patients were selected via stratified sampling in three shifts (morning, evening, and night). The datasheet was used to record errors in the three shifts. This research was conducted, using the DMAIC cycle's "define" and "measure" steps. In the define step, the hemovigilance process at Afzalipour Hospital was divided into two categories of normal process and emergency process. Each of these processes consists of several sub-processes, including "phlebotomy," "requesting blood and blood products from the department," "preparation of application by the blood bank," " sending a request from the blood bank to the blood transfusion center," "transfusing blood and blood products," and "returning the blood and blood products to the blood bank and waste disposal." In the measure step, the quality of hemovigilance process was evaluated based on sub-processes and labels at morning, evening and night shifts. The sub-process of sending a request from the blood bank to the blood transfusion center had the highest error rate with a sigma level of 1.5. Also, the evening and night shifts had a sigma level of 1.875, and the clinical and registration labels had a sigma level of 1.875. The overall sigma level of hemovigilance process was calculated to be 2. The results of this study showed that the quality of hemovigilance process at Afzalipour Hospital was poor. By employing the first two steps of Six Sigma method, we identified the existing errors in the hemovigilance process of Afzalipour hospital in order to assist hospital managers to take the necessary measures to improve this process.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Hemovigilance is a set of monitoring methods that covers the blood transfusion chain, from collecting blood and blood products to monitoring the blood recipients. To this end, any error in this process can have serious and irreparable consequences for patients. The present study aimed to investigate the quality of hemovigilance process in Iran, using the first two steps of Six Sigma model.
METHODS
METHODS
This was a quantitative cross-sectional study that was conducted over 6 months (from August 20, 2021, to February 20, 2022) at Afzalipour Hospital in Iran, using the first two steps of Six Sigma model. The study population comprised of all inpatients who needed blood or blood product transfusion in various departments of Afzalipour Hospital, among whom 477 patients were selected via stratified sampling in three shifts (morning, evening, and night). The datasheet was used to record errors in the three shifts. This research was conducted, using the DMAIC cycle's "define" and "measure" steps.
RESULTS
RESULTS
In the define step, the hemovigilance process at Afzalipour Hospital was divided into two categories of normal process and emergency process. Each of these processes consists of several sub-processes, including "phlebotomy," "requesting blood and blood products from the department," "preparation of application by the blood bank," " sending a request from the blood bank to the blood transfusion center," "transfusing blood and blood products," and "returning the blood and blood products to the blood bank and waste disposal." In the measure step, the quality of hemovigilance process was evaluated based on sub-processes and labels at morning, evening and night shifts. The sub-process of sending a request from the blood bank to the blood transfusion center had the highest error rate with a sigma level of 1.5. Also, the evening and night shifts had a sigma level of 1.875, and the clinical and registration labels had a sigma level of 1.875. The overall sigma level of hemovigilance process was calculated to be 2.
CONCLUSION
CONCLUSIONS
The results of this study showed that the quality of hemovigilance process at Afzalipour Hospital was poor. By employing the first two steps of Six Sigma method, we identified the existing errors in the hemovigilance process of Afzalipour hospital in order to assist hospital managers to take the necessary measures to improve this process.
Identifiants
pubmed: 37891622
doi: 10.1186/s12913-023-10113-6
pii: 10.1186/s12913-023-10113-6
pmc: PMC10605775
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1169Informations de copyright
© 2023. The Author(s).
Références
BMC Health Serv Res. 2017 Jun 30;17(1):453
pubmed: 28666439
Vox Sang. 2022 Nov;117(11):1271-1278
pubmed: 36102136
Vox Sang. 2014 Aug;107(2):153-7
pubmed: 24602024
J Pak Med Assoc. 2020 Apr;70(4):694-698
pubmed: 32296217
Transfus Med Rev. 2021 Apr;35(2):135-139
pubmed: 33849745
Clin Chem Lab Med. 2012 Nov;50(11):1935-43
pubmed: 23093085
J Healthc Risk Manag. 2021 Oct;41(2):18-30
pubmed: 33434405
Transfusion. 2014 Jan;54(1):66-73; quiz 65
pubmed: 23672511
Asian J Transfus Sci. 2015 Jan-Jun;9(1):36-40
pubmed: 25722571
Indian J Hematol Blood Transfus. 2019 Apr;35(2):304-312
pubmed: 30988568
Nurs Open. 2022 Jul;9(4):1967-1979
pubmed: 34047058
Transfus Apher Sci. 2020 Aug;59(4):102812
pubmed: 32439491
Transfus Apher Sci. 2014 Feb;50(1):111-7
pubmed: 24239270
BMC Nurs. 2021 Apr 12;20(1):60
pubmed: 33845822
Transfusion. 2019 Feb;59(2):516-523
pubmed: 30609064
Asian J Transfus Sci. 2016 Jan-Jun;10(1):48-52
pubmed: 27011670
Transfus Med. 2011 Jun;21(3):183-9
pubmed: 21272102